Skip to main content

Weather Alert

Hurricane activity is severely impacting Quest locations across the Southeast. We ask that patients please double check your appointment status to ensure your designated Patient Service Center is operational.

Hide
Quest Diagnostics

Development of a 25-Marker Flow Cytometry Assay Interrogating All Major Hematopoietic Cell Populations

38th International Clinical Cytometry Meeting & Course

ICCS 2023

New Orleans, LA,  Sep 29-Oct 3, 2023

Poster presentation: Development of a 25-Marker Flow Cytometry Assay Interrogating All Major Hematopoietic Cell Populations

Authors: Radetskaya O, Kussick SJ

Specialty: Oncology, Hematology, Coagulation

Disclaimer: One or more of the authors of this abstract were employed at the time by PhenoPath, a subsidiary of Quest Diagnostics.

Related content

Publication
Prevalence of Suspected Direct Oral Anticoagulant Interference on Thrombophilia Testing
On-Demand Webinar
Women and Heart Disease: Is There Really a Sex Difference?

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.